Synthesis of peptidomimetics, δ- And ε-lactam tetrazoles

Molecular Diversity

Volumn 16, Issue 3, 2012, Pages 601-606

  Gunawan, Steven ^a   Keck, Kristen ^a   Laetsch, Alex ^a   Hulme, Christopher ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

1,5 disubstitutedtetrazoles; Multi component reactions (MCRs); Ugi reaction

Indexed keywords

1 (3,4 DIMETHOXYBENZYL) 6 [1 (2,6 DIMETHYLPHENYL) 1H TETRAZOL 5 YL] 6 METHYLPIPERIDIN 2 ONE; 1 (FURAN 2 YLMETHYL) 6 METHYL 6 (1 PENTYL 1H TETRAZOL 5 YL)PIPERIDIN 2 ONE; 1 (FURAN 2 YLMETHYL) 7 METHYL 7 (1 PENTYL 1H TETRAZOL 5YL)AZEPAN 2 ONE; 5 OXOHEXANOIC ACID; 6 (1 BENZYL 1H TETRAZOL 5 YL) 6 METHYL 1 (THIOPHEN 2 YLMETHYL)PIPERIDIN 2 ONE; 6 (1 CYCLOHEXYL 1H TETRAZOL 5 YL) 1 (4 HYDROXYPHENETHYL) 6 METHYLPIPERIDIN 2 ONE; 6 (1 CYCLOPENTYL 1H TETRAZOL 5 YL) 1 (2,5 DIMETHOXYBENZYL) 6 METHYLPIPERIDIN 2 ONE; 6 [1 (2,3 DIHYDROBENZO[B][1,4]DIOXIN 6 YL) 1H TETRAZOL 5 YL] 1 (4 METHOXYBENZYL) 6 METHYLPIPERIDIN 2 ONE; 6 OXOHEXANOIC ACID; 7 (1 BENZYL 1H TETRAZOL 5 YL) 7 METHYL 1 (THIOPHEN 2 YLMETHYL)AZEPAN 2 ONE; 7 (1 CYCLOPENTYL 1H TETRAZOL 5 YL) 1 (2,5 DIMETHOXYBENZYL 7 METHYLAZEPAN 2 ONE; 7 (1 ISOPROPYL 1H TETRAZOL 5 YL) 7 METHYL 1 [3 (TRIFLUOROMETHYL)BENZYL]AZEPAN 2 ONE; 7 [1 (2,6 DIMETHYLPHENYL 1H TETRAZOL 5 YL) 1 (4 METHOXYBENZYL) 7 METHYLAZEPAN 2 ONE; AMINE; AZIDOTRIMETHYLSILANE; CYANIDE; DELTA LACTAM TETRAZOLE DERIVATIVE; EPSILON LACTAM TETRAZOLE DERIVATIVE; HEXANOIC ACID; PEPTIDOMIMETIC AGENT; SILANE DERIVATIVE; TETRAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL REACTION; CHEMICAL REACTION KINETICS; DRUG SYNTHESIS; HYDROLYSIS; PRIORITY JOURNAL;

CHEMISTRY TECHNIQUES, SYNTHETIC; DITERPENES, KAURANE; LACTAMS; PEPTIDOMIMETICS; TETRAZOLES;

EID: 84869432186     PISSN: 13811991     EISSN: 1573501X     Source Type: Journal    
DOI: 10.1007/s11030-012-9373-2     Document Type: Article

References (22)

1. Zabrocki J, Smith GD, Dunbar JB Jr, Iijima H, Marshall GR (1988) Conformationalmimicry. 1. 1,5-Disubstituted tetrazole ring as a surrogate for the cis amide bond. J Am Chem Soc 110:5875- 5880. doi:10.1021/ja00225a045
2. Creighton CJ, Leo GC, DuW, Reitz AB (2004) Design, synthesis, and conformational analysis of eight-membered cyclic peptidomimetics prepared using ring closing metathesis. Bioorg Med Chem 12:4375-4385. doi:0.1016/j.bmc.2004.06. 015 (Pubitemid 39055641)
3. Kang SY, Lee S-H, Seo HJ, Jung ME, Ahn K, Kim J, Lee J (2008) Tetrazole-biarylpyrazole derivatives as cannabinoid CB1 receptor antagonists. Bioorg Med Chem Lett 18:2385-2389. doi:10.1016/j.bmcl.2008.02.061 (Pubitemid 351442896)
4. Muraglia E, Kinzel OD, Laufer R, Miller MD, Moyer G, Munshi V, Orvieto F, Palumbi MC, Pescatore G, Rowley M, Williams PD, Summa V (2006) Tetrazolethioacetanilides: potent non-nucleoside inhibitors of WT HIV reverse transcriptase and its K103N mutant. Bioorg Med Chem Lett 16:2748-2752. doi:10.1016/j.bmcl.2006.02.024
5. O'Meara JA, Jakalian A, LaPlante S, Bonneau PR, Coulombe R, Faucher AM, Guse I, Landry S, Racine J, Simoneau B, Thavonekham B, Yoakim C (2007) Scaffold hopping in the rational design of novel HIV-1 non-nucleoside reverse transcriptase inhibitors. Bioorg Med Chem Lett 17:3336-3362. doi:10.1016/j.bmcl.2007.03.097 (Pubitemid 46819032)
6. Al-Hourani BJ, Sharma SK, Mane JY, Tuszynski J, Baracos V, Kniess T, Suresh M, Pietzsch J, Wuest F (2011) Synthesis and evaluation of 1,5-diaryl-substituted tetrazoles as novel selective cyclooxygenase-2 (COX-2) inhibitors. Bioorg Med Chem Lett 21: 1823-1826. doi:10.1016/j.bmcl.2011.01.057
7. Van Poecke S, Negri A, Janssens J, Solaroli N, Karlsson A, Gago F, Balzarini J, Van Calenbergh S (2011) Synthesis, modeling and evaluation of 3′-(1-aryl-1H-tetrazol-5-ylamino)-substituted 3′-deoxythymidine derivatives as potent and selective human mitochondrial thymidine kinase inhibitors. Org Biomol Chem 9: 892-901. doi:10.1039/C0OB00591F
8. Alexander JP, Cravatt BF (2006) The putative endocannabinoid transport blocker LY2183240 is a potent inhibitor of FAAH and several other brain serine hydrolases. J Am Chem Soc 128: 9699-9704. doi:10.1021/ja062999h (Pubitemid 44147953)
9. Hulme C, Tempest P, Ma V, Nixey T, Balow G (2005) PCT Int Appl, 260 pp. WO 2005019167.
10. Tempest P, Nixey T, Ma V, Balow G, van Staden C, Salon J, Rorer K, Baumgartner J, Hale C, Bannon T, Hungate R, Hulme C (2004) Novel potent tetrazole containing melanin concentrating hormone (MCH) receptor antagonists multi-component reactions lead the way. Abstract of Papers, 227th National Meeting of the American Chemical Society, Anaheim, CA: American Chemical Society: Washington, DC, 2004; MEDI 298
11. Nixey T, Boylan J, Hulme C, Powers D, Smith A, Wong A (2006) Inhibitors of the polo-like protein kinase Plk-1. Abstract of Papers, 231st National Meeting of the American Chemical Society, Atlanta, GA; American Chemical Society: Washington, DC, 2006; MEDI 277
12. Li J, Chen SY, Li JJ, Wang H, Hernandez AS, Tao S, Musial CM, Qu F, Swartz S, Chao ST, Flynn N, Murphy BJ, Slusarchyk DA, Seethala R, Yan M, Sleph P, Grover G, Smith MA, Beehler B, Giupponi L, Dickinson KE, Zhang H, HumphreysWG, Patel BP, SchwindenM, Stouch T, Cheng PTW, Biller SA, Ewing WR, Gordon D, Robl JA, Tino JA (2007) Discovery of a tetrazole-based growth hormone secretagogue: 4-(hydroxybutyl)carbamic acid 2-{5-[1-(2-amino-2- methylpropionylamino)-2-benzyloxyethyl] tetrazol-1-yl}ethyl ester (BMS-317180). J Med Chem 50:5890-5893. doi:10.1021/jm7010595
13. Hernández AS, Cheng PTW, Musial CM, Swartz SG, George RJ, Grover G, Slusarchyk D, Seethala RK, Smith M, Dickinson K, Giupponi L, Longhi DA, Flynn N, Murphy BJ, Gordon DA, Biller SA, Robl JA, Tino JA (2007) Discovery, synthesis, and structure- activity studies of tetrazole based growth hormone secretagogues. Bioorg Med Chem Lett 17:5928-5933. doi:10.1016/j.bmcl.2007.07.099 (Pubitemid 47446207)
14. Ugi I (1962) The α-addition of immonium ions and anions to isonitriles accompanied by secondary reactions. Angew Chem Int Ed 1:8-21. doi:10.1002/anie.196200081
15. Nixey T, Kelly M, Hulme C (2000) The one-pot solution phase preparation of fused tetrazole-ketopiperazines. Tetrahedron Lett 41:8729-8733. doi:10.1016/S0040-4039(00)01563-X
16. Domling A (2006) Recent developments in isocyanide based multicomponent reactions in applied chemistry. Chem Rev 106:17-89. doi:10.1021/cr0505728 (Pubitemid 43159621)
17. Weber L (2000) High-diversity combinatorial libraries. Curr Opin Chem Biol 4:295-302. doi:10.1016/S1367-5931(00)00092-2 (Pubitemid 30319053)
18. Hulme C, Gore V (2003) Multi-component reactions: emerging chemistry in drug discovery 'From xylocain to crixivan'. Curr Med Chem 10:51-80. doi:10.2174/0929867033368600 (Pubitemid 36131649)
19. Banfi L, Riva R, Basso A (2010) Coupling isocyanide-based multicomponent reactions with aliphatic or acyl nucleophilic substitution processes. Synlett 1:23-41. doi:10.1055/s-0029-1218527
20. Ilyn AP, Loseva MV, Vvedensky VY, Putsykina EB, Tkachenko SE, Kravchenko DV, Khvat AV, Krasavin MY, Ivachtchenko AV (2006) One-step assembly of carbamoyl-substituted heteroannelated [1,4]thiazepines. J Org Chem 71:2811-2819. doi:10.1021/jo052640w
21. El Kaim L, Grimaud L (2009) Beyond the Ugi reaction: less conventional interactions between isocyanides and iminium species. Tetrahedron 65:2153-2171. doi:10.1016/j.tet.2008.12.002
22. Gunawan S, Petit J, Hulme C (2012) Concise one-pot preparation of unique bis-pyrrolidinone tetrazoles. ACS Comb Sci 14:160-163. doi:10.1021/co200209a